CD4 and metabolic dysfunction-associated steatohepatitis: Obviously, JZG could reduce damage to immunologic barrier of intestinal mucosa in NASH rats with concomitant promotion of the maturation of intestinal mucosal DCs, and DCs-induced differentiation of naive CD4+ T cells into Th1 cells for the protection of intestinal mucosal immune barrier.